Invention Application
- Patent Title: Hepatitis C Virus Inhibitors
-
Application No.: US13919027Application Date: 2013-06-17
-
Publication No.: US20130280211A1Publication Date: 2013-10-24
- Inventor: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. ST. Laurent , Fukang Yang , David R. Langley , Lawrence G. Hamann
- Applicant: Bristol-Myers Squibb Company
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D401/14 ; A61K45/06 ; A61K31/5377 ; C07F7/10 ; A61K31/695 ; A61K31/4178 ; A61K31/4545
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Public/Granted literature
- US09018390B2 Hepatitis C virus inhibitors Public/Granted day:2015-04-28
Information query
